GSA CAPITAL PARTNERS LLP - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 73 filers reported holding ENZO BIOCHEM INC in Q2 2021. The put-call ratio across all filers is 2.53 and the average weighting 0.4%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q1 2021$41,000
-59.4%
11,807
-70.6%
0.01%
-58.8%
Q4 2020$101,000
-28.4%
40,172
-39.7%
0.02%
-29.2%
Q3 2020$141,000
+354.8%
66,672
+379.3%
0.02%
+41.2%
Q2 2020$31,000
-32.6%
13,911
-20.9%
0.02%
+240.0%
Q4 2019$46,000
-63.2%
17,593
-49.4%
0.01%
-70.6%
Q3 2019$125,000
-51.2%
34,793
-54.2%
0.02%
-41.4%
Q2 2019$256,000
+52.4%
75,900
+23.2%
0.03%
+70.6%
Q1 2019$168,000
-1.8%
61,600
-0.1%
0.02%
-15.0%
Q4 2018$171,000
-32.7%
61,6570.0%0.02%
+42.9%
Q3 2018$254,000
-53.7%
61,657
-41.7%
0.01%
-48.1%
Q2 2018$549,000
-30.2%
105,700
-26.3%
0.03%
-35.7%
Q1 2018$786,000
-31.5%
143,400
+1.9%
0.04%
-40.0%
Q4 2017$1,147,000
-24.0%
140,700
-2.4%
0.07%
-32.0%
Q3 2017$1,509,000
-20.4%
144,091
-16.1%
0.10%
-16.9%
Q2 2017$1,895,000
-28.6%
171,691
-45.8%
0.12%
-12.7%
Q1 2017$2,653,000
+45.3%
316,931
+20.5%
0.14%
+30.3%
Q4 2016$1,826,000
+124.6%
263,100
+64.6%
0.11%
+147.7%
Q3 2016$813,000
+30.3%
159,808
+52.9%
0.04%
+29.4%
Q2 2016$624,000
-25.4%
104,508
-43.2%
0.03%
-35.8%
Q1 2016$837,000
-28.3%
184,027
-29.1%
0.05%
-7.0%
Q4 2015$1,168,000
+33.5%
259,527
-6.0%
0.06%
+32.6%
Q3 2015$875,000
+17.9%
276,098
+12.7%
0.04%
+53.6%
Q2 2015$742,000
+137.1%
244,894
+130.8%
0.03%
+133.3%
Q1 2015$313,000
-6.3%
106,096
+41.0%
0.01%
-47.8%
Q4 2014$334,000
+384.1%
75,226
+463.7%
0.02%
+475.0%
Q3 2014$69,000
-61.5%
13,345
-60.9%
0.00%
-50.0%
Q2 2014$179,000
-3.2%
34,093
-46.2%
0.01%
-46.7%
Q4 2013$185,000
+6.9%
63,393
-7.4%
0.02%
+7.1%
Q3 2013$173,000
+15.3%
68,493
-5.1%
0.01%
-22.2%
Q2 2013$150,00072,1930.02%
Other shareholders
ENZO BIOCHEM INC shareholders Q2 2021
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,392,642$6,939,00011.21%
VIEX Capital Advisors, LLC 1,435,130$4,162,0007.44%
HARBERT FUND ADVISORS, INC. 5,175,913$15,010,0006.29%
Potomac Capital Management, Inc. 496,805$1,441,0001.24%
AMH Equity Ltd 30,000$87,0000.09%
Corsair Capital Management 75,026$218,0000.05%
RBF Capital, LLC 250,359$730,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$74,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 539,954$1,566,0000.04%
Cutter & CO Brokerage, Inc. 25,777$75,0000.02%
View complete list of ENZO BIOCHEM INC shareholders